Chi Zuo-Hua, Zhu Ping
Clinical Medicine College, Guangdong Pharmaceutical University; Guangzhou 510310, Guangdong Province, China; Institute of Hematology & Oncology, Beijing Aerospace General Hospital, Beijing 100076,China.
Department of Hematology, Peking University First Hospital, Beijing 100034, China. E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Oct;25(5):1580-1584. doi: 10.7534/j.issn.1009-2137.2017.05.053.
Severe congenital neutropenia (SCN) is a rare disease of bone marrow failure. Absolute value of peripheral blood neutrophil of SCN significantly reduced. SCN has a high risk of transformation to myelodysplastic syndromes (MDS) / acute myeloid leukemia (AML). At present, there are 14 abnormal genes related to SCN, ELANE is the most common pathogenic gene, the main therapy of SCN is the application of granulocyte colony stimulating factor (G-CSF). CSF3R gene mutation often occurs in the treatment process, and can lead to acute myeloid leukemia. Further research on SCN/AML transformation mechanism is helpful to the diagnosis and treatment of this disease. This review focuses on the genetics and phenotypic polymorphysm in SCN patients, the therapeutic effect and risk of G-CSF for SCN patients, the effect of CSF3R matation on signal transduction of G-CSF, CSF3R mutation is important factor for SCN tranformation to acute myeloid leukemia, exploring the mechanism of SCN/AML transformation contributes to diagnosis and therapy for patients and so on.
严重先天性中性粒细胞减少症(SCN)是一种罕见的骨髓衰竭疾病。SCN患者外周血中性粒细胞绝对值显著降低。SCN转化为骨髓增生异常综合征(MDS)/急性髓系白血病(AML)的风险很高。目前,有14个与SCN相关的异常基因,ELANE是最常见的致病基因,SCN的主要治疗方法是应用粒细胞集落刺激因子(G-CSF)。CSF3R基因突变常发生在治疗过程中,并可导致急性髓系白血病。对SCN/AML转化机制的进一步研究有助于该病的诊断和治疗。本文综述聚焦于SCN患者的遗传学和表型多态性、G-CSF对SCN患者的治疗效果和风险、CSF3R突变对G-CSF信号转导的影响、CSF3R突变是SCN转化为急性髓系白血病的重要因素、探索SCN/AML转化机制有助于患者的诊断和治疗等方面。